Prescription drug · ANDA
Indapamide NDC 16571-876
Indapamide 2.5 mg/1 · Tablet · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16571-876-01 | 16571087601 | 100 TABLET in 1 BOTTLE (16571-876-01)Marketed from Jun 22, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Indapamide
- Generic name (nonproprietary)
- indapamide
- Active ingredients
- Indapamide — 2.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 16571
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074461
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis (Physiologic effect)
- Identifiers
- Product ID 16571-876_7c1bd14b-7f8f-4ad6-9c3c-e6a0d9aad1cfSPL ID 7c1bd14b-7f8f-4ad6-9c3c-e6a0d9aad1cfSPL set ID 0687ed93-4761-4f9c-887d-95309c03f60eRxCUI 197815, 197816UNII F089I0511LUPC 0316571875016, 0316571876013
- Pharmacologic class
- Thiazide-like Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416571087601followed by a unit qualifier and the quantityPackage 16571-0876-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. Indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. Usage in Pregnancy : The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see PRECAUTIONS below). Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. Edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conse…
Excerpt only. Read the full label for complete information.
About NDC 16571-876
- What is NDC 16571-876?
- 16571-876 is the product NDC for Indapamide, Indapamide 2.5 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Indapamide.
- What is the active ingredient?
- Indapamide.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Indapamide?
- 15 other product NDCs are listed under this name. See all Indapamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Indapamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Indapamide | Indapamide 2.5 mg/1 | Tablet, Film coatedOral | Direct_Rx | 72189-591 | 72189-0591-60 |
| Indapamide | Indapamide 1.25 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-875 | 16571-0875-01 |
| Indapamide | Indapamide 2.5 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | 68788-7247 | 68788-7247-0168788-7247-0368788-7247-06+1 more |
| Indapamide | Indapamide 2.5 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-7826 | 50090-7826-01 |
| Indapamide | Indapamide 1.25 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-7828 | 50090-7828-00 |
| Indapamide | Indapamide 1.25 mg/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | 62559-510 | 62559-0510-01 |
| Indapamide | Indapamide 2.5 mg/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | 62559-511 | 62559-0511-01 |
| Indapamide | Indapamide 1.25 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1953 | 63629-1953-01 |
| Indapamide | Indapamide 2.5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1954 | 63629-1954-01 |
| Indapamide | Indapamide 1.25 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-1541 | 71335-1541-0171335-1541-02 |
Other NDCs under ANDA 074461
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Indapamide | Indapamide 1.25 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-875 |